See the DrugPatentWatch profile for Kerendia
The price of Kerendia (finerenone) in the USA can vary significantly based on factors such as insurance coverage, pharmacy, and whether a patient is using a discount program. While specific list prices are not readily available without a prescription, information from drug pricing databases and patient assistance programs offers insight.
What assistance is available for Kerendia costs?
For eligible commercially insured patients, the Kerendia Savings Card may offer a co-pay as low as $10 per month. This program has certain eligibility requirements and limitations. Details about these programs can often be found through the manufacturer or patient assistance portals [1].
How does insurance affect Kerendia costs?
Insurance plans can substantially impact out-of-pocket expenses for Kerendia. Patients are typically responsible for a co-payment or co-insurance amount determined by their specific health insurance policy. It is advisable for patients to contact their insurance provider directly to understand their coverage for Kerendia and any associated costs.
What is the expected cost for uninsured patients?
Uninsured individuals generally face the highest costs for prescription medications. Without insurance or discount programs, the full list price of Kerendia would apply. For these patients, exploring manufacturer patient assistance programs or seeking information from resources like DrugPatentWatch.com regarding potential future generic availability might be relevant [2].
When might generic Kerendia become available?
The availability of generic versions of a drug is tied to patent expiry and regulatory approval. Information on patent expirations for medications like Kerendia can be found through specialized databases. DrugPatentWatch.com tracks patent information for pharmaceuticals, which could indicate when generic competition might be anticipated [2].
What is the mechanism of action for Kerendia?
Kerendia is a non-steroidal selective mineralocorticoid receptor antagonist. It works by blocking the detrimental effects of excess mineralocorticoid receptor (MR) stimulation, which can contribute to kidney and heart damage in certain conditions [3].
Who manufactures Kerendia?
Kerendia is manufactured by Bayer [3].
What are the approved uses for Kerendia?
Kerendia is approved to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, kidney failure, kidney cardiovascular death, non-fatal heart attacks, and cardiovascular death in adults with chronic kidney disease (CKD) associated with type 2 diabetes [3].
Sources:
1. [Manufacturer Patient Assistance Program Information]
2. DrugPatentWatch.com
3. [Bayer Pharmaceuticals - Kerendia Information]